Promis Neurosciences (Germany) Performance

23J Stock  EUR 13.40  0.20  1.47%   
Promis Neurosciences holds a performance score of 13 on a scale of zero to a hundred. The company holds a Beta of -1.24, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Promis Neurosciences are expected to decrease by larger amounts. On the other hand, during market turmoil, Promis Neurosciences is expected to outperform it. Use Promis Neurosciences downside deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to analyze future returns on Promis Neurosciences.

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Promis Neurosciences are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Promis Neurosciences reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor
1:25
Last Split Date
2025-11-28
1
Why ProMIS Neurosciences Inc. stock appeals to analysts - Quarterly Investment Review Weekly Consistent Profit Watchlists - ulpravda.ru
01/08/2026
2
Market Moves Can ProMIS Neurosciences Inc continue delivering strong returns - Market Growth Summary Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
01/13/2026
3
Alzheimers biotech ProMIS to stream Guggenheim summit fireside chat - stocktitan.net
02/04/2026
  

Promis Neurosciences Relative Risk vs. Return Landscape

If you would invest  805.00  in Promis Neurosciences on November 9, 2025 and sell it today you would earn a total of  535.00  from holding Promis Neurosciences or generate 66.46% return on investment over 90 days. Promis Neurosciences is currently producing 1.0342% returns and takes up 6.2248% volatility of returns over 90 trading days. Put another way, 55% of traded stocks are less volatile than Promis, and 80% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Promis Neurosciences is expected to generate 7.6 times more return on investment than the market. However, the company is 7.6 times more volatile than its market benchmark. It trades about 0.17 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of risk.

Promis Neurosciences Target Price Odds to finish over Current Price

The tendency of Promis Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 13.40 90 days 13.40 
near 1
Based on a normal probability distribution, the odds of Promis Neurosciences to move above the current price in 90 days from now is near 1 (This Promis Neurosciences probability density function shows the probability of Promis Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Promis Neurosciences has a beta of -1.24. This suggests as returns on its benchmark rise, returns on holding Promis Neurosciences are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Promis Neurosciences is expected to outperform its benchmark. Additionally Promis Neurosciences has an alpha of 0.9, implying that it can generate a 0.9 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Promis Neurosciences Price Density   
       Price  

Predictive Modules for Promis Neurosciences

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Promis Neurosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
7.2313.5119.79
Details
Intrinsic
Valuation
LowRealHigh
3.429.7015.98
Details
Naive
Forecast
LowNextHigh
9.7115.9922.27
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
3.857.5911.33
Details

Promis Neurosciences Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Promis Neurosciences is not an exception. The market had few large corrections towards the Promis Neurosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Promis Neurosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Promis Neurosciences within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.90
β
Beta against Dow Jones-1.24
σ
Overall volatility
1.55
Ir
Information ratio 0.12

Promis Neurosciences Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Promis Neurosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Promis Neurosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Promis Neurosciences is way too risky over 90 days horizon
Promis Neurosciences appears to be risky and price may revert if volatility continues
Promis Neurosciences has high likelihood to experience some financial distress in the next 2 years
Promis Neurosciences has accumulated about 21.5 M in cash with (27.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05.
Roughly 25.0% of the company shares are owned by insiders or employees
Latest headline from news.google.com: Alzheimers biotech ProMIS to stream Guggenheim summit fireside chat - stocktitan.net

Promis Neurosciences Fundamentals Growth

Promis Stock prices reflect investors' perceptions of the future prospects and financial health of Promis Neurosciences, and Promis Neurosciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Promis Stock performance.

About Promis Neurosciences Performance

By analyzing Promis Neurosciences' fundamental ratios, stakeholders can gain valuable insights into Promis Neurosciences' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Promis Neurosciences has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Promis Neurosciences has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimers disease , amyotrophic lateral sclerosis , and multiple system atrophy in Canada. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada. PROMIS NEUROSCIENCES operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 5 people.

Things to note about Promis Neurosciences performance evaluation

Checking the ongoing alerts about Promis Neurosciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Promis Neurosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Promis Neurosciences is way too risky over 90 days horizon
Promis Neurosciences appears to be risky and price may revert if volatility continues
Promis Neurosciences has high likelihood to experience some financial distress in the next 2 years
Promis Neurosciences has accumulated about 21.5 M in cash with (27.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05.
Roughly 25.0% of the company shares are owned by insiders or employees
Latest headline from news.google.com: Alzheimers biotech ProMIS to stream Guggenheim summit fireside chat - stocktitan.net
Evaluating Promis Neurosciences' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Promis Neurosciences' stock performance include:
  • Analyzing Promis Neurosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Promis Neurosciences' stock is overvalued or undervalued compared to its peers.
  • Examining Promis Neurosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Promis Neurosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Promis Neurosciences' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Promis Neurosciences' stock. These opinions can provide insight into Promis Neurosciences' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Promis Neurosciences' stock performance is not an exact science, and many factors can impact Promis Neurosciences' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Promis Stock analysis

When running Promis Neurosciences' price analysis, check to measure Promis Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Promis Neurosciences is operating at the current time. Most of Promis Neurosciences' value examination focuses on studying past and present price action to predict the probability of Promis Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Promis Neurosciences' price. Additionally, you may evaluate how the addition of Promis Neurosciences to your portfolios can decrease your overall portfolio volatility.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities